Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 176,207 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Follow-Up Questions
Fresenius SE & Co KGaA (FSNUY) 的市盈率是多少?
Fresenius SE & Co KGaA 的市盈率是 N/A
FSNUY 股票的价格表现如何?
FSNUY 的当前价格为 13.95,在上个交易日 decreased 了 0%。
Fresenius SE & Co KGaA 的主要业务主题或行业是什么?
Fresenius SE & Co KGaA 属于 Health Care 行业,该板块是 Health Care
Fresenius SE & Co KGaA 的市值是多少?
Fresenius SE & Co KGaA 的当前市值是 $31.4
Fresenius SE & Co KGaA 是买入、卖出还是持有?
据华尔街分析师称,共有 21 位分析师对 Fresenius SE & Co KGaA 进行了分析师评级,包括 9 位强烈买入,11 位买入,3 位持有,0 位卖出,以及 9 位强烈卖出